Improved Genetic Characterization of Hypercholesterolemia in Latvian Patients with Familial Hypercholesterolemia: A Combined Monogenic and Polygenic Approach Using Whole-Genome Sequencing
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413466 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ivanna Atava und 9 weiteren Autor:innen. Beteiligte Einrichtung: Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Whole Genome Sequencing, Multifactorial Inheritance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Latvian Council of Science.
Abstract (Originalsprache)
Despite the implementation of next-generation sequencing-based genetic testing on patients with clinical familial hypercholesterolemia (FH), most cases lack complete genetic characterization. We aim to investigate the utility of the polygenic risk score (PRS) in specifying the genetic background of patients from the Latvian Registry of FH (LRFH). We analyzed the whole-genome sequencing (WGS) data of the clinically diagnosed FH patients (n = 339) and controls selected from the Latvian reference population (n = 515). Variant pathogenicity in FH patients was classified according to the ACMG/AMP guidelines. The low-density lipoprotein cholesterol (LDL-C) and lipoprotein (a) (LPA) PRS were calculated based on the WGS data. We identified unique causative variants in 80 (23.6%) of the tested individuals (39 variants in FH genes and 4 variants in phenocopy genes, with 6 variants being novel). The LDL-C PRS was highly discriminative compared to the LPA PRS. Nevertheless, both PRS were able to explain the genetic cause of hypercholesterolemia in 26.3% of the remaining non-monogenic patients. The combined genetic analysis of monogenic and polygenic hypercholesterolemia resulted in 43.7% genetically explained hypercholesterolemia cases. Even though the application of PRS alone does not exclude monogenic testing in clinical FH patients, it is a valuable tool for diagnosis specification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.
- Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.
- Faculty of Medicine and Life Sciences, University of Latvia, LV-1004 Riga, Latvia.
- Latvian Center of Cardiology, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.
ORCID-Profile: Ivanna Atava, Vita Saripo, Ruta Meiere, Gunda Skudrina, Janis Klovins, Gustavs Latkovskis
Förderung
- Latvian Council of Science
Zitieren
APA
Atava, I., Briviba, M., Nesterovics, G., Saripo, V., Gilis, D., Meiere, R., Terauda, E., Skudrina, G., Klovins, J., & Latkovskis, G. (2024). Improved Genetic Characterization of Hypercholesterolemia in Latvian Patients with Familial Hypercholesterolemia: A Combined Monogenic and Polygenic Approach Using Whole-Genome Sequencing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413466
Vancouver
Atava I, Briviba M, Nesterovics G, Saripo V, Gilis D, Meiere R, et al. Improved Genetic Characterization of Hypercholesterolemia in Latvian Patients with Familial Hypercholesterolemia: A Combined Monogenic and Polygenic Approach Using Whole-Genome Sequencing. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413466
BibTeX
@article{Atava2024,
author = {Atava, Ivanna and Briviba, Monta and Nesterovics, Georgijs and Saripo, Vita and Gilis, Dainus and Meiere, Ruta and Terauda, Elizabete and Skudrina, Gunda and Klovins, Janis and Latkovskis, Gustavs},
title = {Improved Genetic Characterization of Hypercholesterolemia in Latvian Patients with Familial Hypercholesterolemia: A Combined Monogenic and Polygenic Approach Using Whole-Genome Sequencing},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413466}
}
EUVIMED